采用经证实的抗菌乳房腔隙冲洗提升美容乳房假体手术患者结局:20年随访
该研究前瞻性记录了1997至2017年接受美容隆乳患者的资料,冲洗采用含聚维酮碘方案或非聚维酮碘三联抗生素方案。共2088例患者4176枚假体,Ⅲ/Ⅳ级包膜挛缩总体发生率为0.57%,聚维酮碘方案与非聚维酮碘方案均有效,前者更受青睐。
要点
- 20年前瞻性数据纳入2088例患者共4176枚假体,其中毛面假体826枚、光面假体1262枚。
- 初次隆乳患者Ⅲ/Ⅳ级包膜挛缩发生率为0.57%,毛面假体为1.21%,光面假体为0.16%。
- 含聚维酮碘与非聚维酮碘三联抗生素冲洗方案均有效,含聚维酮碘方案更受青睐。
核心结论
- 本研究是受控的单术者环境下规模最大、随访时间最长的包膜挛缩回顾,包膜挛缩发生率低,强化了抗菌乳房腔隙冲洗的有效性与实用性。
- 含聚维酮碘方案与非聚维酮碘抗生素方案均被发现有成效,其中含聚维酮碘方案更受青睐。
- 推荐普遍采用含聚维酮碘的抗菌乳房腔隙冲洗以减少包膜挛缩及其他器械相关感染。
研究设计与样本
- 前瞻性记录1997至2017年接受美容隆乳患者的数据,冲洗采用含聚维酮碘方案(50%聚维酮碘或「聚维酮碘三联」)或非聚维酮碘三联抗生素方案。
- 共纳入2088例患者、4176枚假体,其中826例患者使用毛面假体,1262例患者使用光面假体。
- 数据库评估假体类型、包膜挛缩发生率及可能的影响因素,包膜挛缩程度按贝克分类记录。
主要发现
- 全部初次隆乳患者Ⅲ/Ⅳ级包膜挛缩发生率为0.57%。
- 毛面假体Ⅲ/Ⅳ级包膜挛缩发生率为1.21%,光面假体为0.16%。
临床怎么用
- 作者推荐普遍采用含聚维酮碘的抗菌乳房腔隙冲洗,以减少包膜挛缩及其他器械相关感染。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Capsular contracture (CC) remains the most common complication of implant-based aesthetic and reconstructive breast surgery. With subclinical infection proven to be the primary etiology, antimicrobial breast pocket irrigation has been recommended as the key step to reduce CC but has not been universally adopted. OBJECTIVES: The purpose of this study was to review the rates of CC observed when applying proven antimicrobial breast pocket irrigations. METHODS: Data from patients undergoing cosmetic breast augmentation were recorded prospectively from 1997 to 2017. The irrigation was performed with either a Betadine-containing (50% Betadine or "Betadine triple") or a non-Betadine triple antibiotic regimen. The database was assessed to determine the type of implant used, the incidence of CC, and possible contributing factors. The degree of CC was recorded according to the Baker classification. RESULTS: A 20-year prospective data collection yielded 2088 patients with 4176 implants; of these patients, 826 had textured implants and 1262 had smooth implants. The incidence of Grade III/IV CC was found to be 0.57% in all patients undergoing primary breast augmentation (1.21% in textured implants and 0.16% in smooth implants). CONCLUSIONS: This study constitutes the largest and longest review of CC in a controlled, single-surgeon setting. The incidence of CC is low and reinforces the efficacy/utility of antimicrobial breast pocket irrigation. Both the Betadine and non-Betadine antibiotic regimens were found to be effective, with the Betadine regimen being preferred. Universal adoption of Betadine-containing antimicrobial breast pocket irrigation is recommended to reduce CC and other device-associated infections.
引用
- Venkataram A, Lahar N, Adams WP, et al. Enhancing Patient Outcomes in Aesthetic Breast Implant Procedures Using Proven Antimicrobial Breast Pocket Irrigations: A 20-Year Follow-up. Aesthet Surg J. 2023. PMID: 36039664. doi:10.1093/asj/sjac238
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。